[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363658-105":59,"doc-detail-363658-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","proteomic-profiling-identifies-an-oncogene-itga2-and-its-downstream-targets-in-gastric-cancer","Proteomic profiling identifies an oncogene ITGA2 and its downstream targets in gastric cancer","","Purpose: Gastric cancer causes high global mortality, and metastasis is the main driver. Tumor-cell exosomes mediate intercellular communication and can prime distant sites by reshaping the microenvironment. The study tests whether gastric cancer exosomes deliver cargo that regulates recipient-cell proteins, promoting tumor progression and metastatic potential. Methods: Exosomes were applied to gastric cancer cell lines; differential proteomics identified altered proteins, while ITGA2 was validated in cells and clinical tissues by RT-qPCR and western blotting. ITGA2 function was assessed via siRNA knockdown, proliferation, and transwell assays, followed by downstream proteomic analysis. Results: Exosomes increased ITGA2 expression and knockdown reduced proliferation, migration, invasion, and enriched adhesion, motility, extracellular matrix and signaling pathways. Conclusion: The exosomes–ITGA2 axis drives oncogenic behavior and may represent a therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/proteomic-profiling-identifies-an-oncogene-itga2-and-its-downstream-targets-in-gastric-cancer/363658/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/proteomic-profiling-identifies-an-oncogene-itga2-and-its-downstream-targets-in-gastric-cancer/363658.png","ImageObject",300,407,{"name":92,"@type":93},"Ben ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What hypothesis does the study test about gastric cancer exosomes?","Question",{"text":112,"@type":113},"It proposes that exosomes released by gastric cancer cells carry cargo that regulates specific proteins in recipient gastric cancer cells, thereby enhancing progression and metastatic potential.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was ITGA2 expression validated in the study?",{"text":117,"@type":113},"ITGA2 was validated in exosome-treated cells and in clinical gastric cancer tissues versus adjacent normal tissues using RT-qPCR and western blotting.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key functional effects of knocking down ITGA2?",{"text":121,"@type":113},"ITGA2 knockdown significantly suppressed cell proliferation, migration, and invasion, and downstream proteomic profiling highlighted pathways related to adhesion, motility, extracellular matrix organization, and intercellular signaling.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363658,1790208714,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Clinical and Translational Oncology (2026) 28:2792–2802  \n[https://doi.org/10.1007/s12094-026-04231-w](https://doi.org/10.1007/s12094-026-04231-w)  \nProteomic profiling identifies an oncogene ITGA2 and its downstream targets in gastric cancer  \nMichelle Xin Liu1 · Kent‑Man Chu1,2  \nReceived: 6 October 2025 / Accepted: 4 January 2026 / Published online: 2 February 2026 © The Author(s) 2026  \nAbstract  \nPurpose Gastric cancer is a leading cause of cancer-related mortality worldwide, with metastasis being the primary cause of death. Exosomes secreted by tumor cells are key mediators of intercellular communication and can prepare distant sites for metastasis by altering the local microenvironment. We hypothesized that exosomes released by gastric cancer cells deliver cargo that regulates specific proteins in recipient gastric cancer cells, thereby enhancing tumor progression and metastatic potential.  \nMethods Human gastric cancer cell lines were treated with exosomes isolated from the conditioned medium of other gastric cancer cells. Differential proteomic analysis was performed to identify proteins significantly altered by exosome treatment. ITGA2 expression was validated in exosome-treated cells and in clinical gastric cancer tissues versus adjacent normal tissues using RT-qPCR and western blotting. The functional role of ITGA2 was assessed by siRNA-mediated knockdown, followed by MTT proliferation assays and fluorometric transwell assays for migration and invasion. A second proteomic analysis was conducted on ITGA2-knockdown versus control cells to identify downstream targets and affected pathways.  \nResults Exosome treatment significantly upregulated ITGA2 expression in recipient gastric cancer cells. ITGA2 was also markedly overexpressed in human gastric cancer tissues compared with adjacent normal mucosa. Knockdown of ITGA2 significantly suppressed cell proliferation, migration, and invasion. Proteomic profiling of ITGA2-knockdown cells revealed numerous differentially expressed proteins enriched in pathways related to cell adhesion, motility, extracellular matrix organization, and intercellular signaling.  \nConclusion Exosomes derived from gastric cancer cells induce ITGA2 overexpression in recipient tumor cells, where ITGA2 functions as an oncogene that promotes proliferation, migration, and invasion. The downstream targets of ITGA2 implicate multiple pro-tumorigenic signaling networks, suggesting that the exosomes–ITGA2 axis may represent a novel therapeutic target in gastric cancer progression and metastasis.  \nKeywords Exosomes · Gastric cancer · ITGA2 · Oncogene  \n* Kent-Man Chuchukm@hku.hk  \nMichelle Xin Liu  \nmelx1301@hku.hk  \n1 Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong, H.K., China  \n2 Department of Surgery, Queen Mary Hospital, Pokfulam, L9-57, Laboratory Block, 21 Sassoon Road, Hong Kong, H.K., China  \nIntroduction  \nGastric cancer (GC) ranks as the fifth most commonly diagnosed malignancy and the fifth leading cause of cancerrelated mortality worldwide, with approximately 970,000 new cases and 660,000 deaths reported in 2022 [1] . It shows substantial geographical variation in incidence, with higher rates in Asia, South America, and Eastern Europe [2, 3], where age-standardized incidence rates remain among the highest globally. In Hong Kong, GC was the sixth leading cause of cancer death in 2023, accounting for 594 fatalities [4] . Radical gastrectomy combined with perioperative chemotherapy represents the cornerstone of curative-intent treatment for localized disease. Nevertheless, a substantial  \nproportion of patients develop recurrence or distant metastasis even after potential curative resection, and therapeutic options for metastatic GC remain limited, resulting in poor prognosis of patients with metastasis. Metastasis is therefore the principal determinant of poor prognosis in GC.  \nExosomes, small extracellular vesicles (30–150 nm) with lipid bilayer membranes, are stable in","cbCaitqGm72kNCXf","https://ap.wps.com/l/cbCaitqGm72kNCXf","pdf",1379778,11,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Gastric cancer burden and metastasis\n## Role of exosomes in cancer progression\n## Prior proteomic biomarker studies","[{\"question\":\"What hypothesis does the study test about gastric cancer exosomes?\",\"answer\":\"It proposes that exosomes released by gastric cancer cells carry cargo that regulates specific proteins in recipient gastric cancer cells, thereby enhancing progression and metastatic potential.\"},{\"question\":\"How was ITGA2 expression validated in the study?\",\"answer\":\"ITGA2 was validated in exosome-treated cells and in clinical gastric cancer tissues versus adjacent normal tissues using RT-qPCR and western blotting.\"},{\"question\":\"What were the key functional effects of knocking down ITGA2?\",\"answer\":\"ITGA2 knockdown significantly suppressed cell proliferation, migration, and invasion, and downstream proteomic profiling highlighted pathways related to adhesion, motility, extracellular matrix organization, and intercellular signaling.\"}]","Proteomic profiling identifies an oncogene ITGA2 and its downstream targets in gastric cancer | PDF",1790152525,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d3b0d8c82d842432c5ecdf3b8d62881.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55b4d9e31be094fe4825ed2956a1d065.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2dfe5acab4d9c9a789c24c1dd06b35d8.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c710c50dbd7ad55994ce4c05566ff598.webp",980,1301]